TBC1D4 and Insulin resistance: Supporting this hypothesis, we report that CM-PA activates PKCθ and ε to induce insulin resistance at the levels of IRS1, Akt Substrate of 160 kDa (AS160), GLUT4 translocation and glucose uptake, along with the induction of pro-inflammatory pathways and increased expression of inflammatory cytokines within muscle cells.